Molecular mechanism of PANoptosis and programmed cell death in neurological diseases

Ketian Hou1, Wenhan Pan1, Lianhui Liu1

  • 1The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

PubMed

Insights

PANoptosis, a cell death pathway integrating pyroptosis, apoptosis, and necroptosis, is crucial in inflammation and cancer. Targeting PANoptosis offers new therapeutic strategies for immune disorders and neurological diseases.

Area of Science:

  • Cellular Biology
  • Immunology
  • Neuroscience

Background:

  • PANoptosis is a programmed cell death pathway involving PANoptosome assembly, integrating pyroptosis, apoptosis, and necroptosis.
  • This pathway coordinates cellular defense against pathogens, inflammation, and oncogenic stress, playing a role in immune-related disorders and cancer.

Purpose of the Study:

  • To systematically review PANoptosome assembly, cell death cascades, and pathological roles in neurological disorders.
  • To propose therapeutic frameworks targeting PANoptosis for precision neurology.

Main Methods:

  • Review of existing literature on PANoptosis, programmed cell death pathways, and neuroinflammation.
  • Analysis of single-cell transcriptomics data revealing PANoptosis signatures in Alzheimer's and multiple sclerosis.
  • Evaluation of preclinical data on PANoptosis-targeted therapies.

Main Results:

  • PANoptosis is implicated in neuroinflammatory disorders, contributing to neuronal loss via crosstalk with other cell death pathways.
  • Distinct PANoptosis signatures are spatially resolved in Alzheimer's and multiple sclerosis, correlating with neuroinflammation.
  • Emerging therapies targeting PANoptosis show preclinical efficacy in neurovascular dysfunction and microglial function.

Conclusions:

  • Dysregulated PANoptosis is a significant factor in neurological disorders, necessitating further mechanistic research.
  • PANoptosis represents a promising therapeutic target for neuroinflammatory conditions and other diseases.
  • Developing precision modulators of PANoptosis is key for next-generation neurological therapies.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K